Norges Bank Arcutis Biotherapeutics, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.24 - $12.53 $1.27 Million - $2.19 Million	174,820 New	174,820 $1.63 Million
Q4 2023 Feb 09, 2024	BUY	$1.84 - $4.82 $149,062 - $390,477	81,012 New	81,012 $261,000
Q3 2023 Nov 13, 2024	BUY	$5.31 - $10.98 $430,173 - $889,511	81,012 New	81,012 $430,000
Q3 2023 Nov 13, 2023	SELL	$5.31 - $10.98 $430,173 - $889,511	-81,012 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$7.51 - $15.0 $704,498 - $1.41 Million	-93,808 Reduced 53.66%	81,012 $772,000
Q2 2023 Aug 14, 2023	SELL	$7.51 - $15.0 $458,981 - $916,740	-61,116 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$10.23 - $17.14 $828,752 - $1.39 Million	81,012 New	81,012 $891,000
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $1.13 Million - $1.65 Million	81,012 New	81,012 $1.2 Million
Q3 2022 Nov 13, 2023	BUY	$17.85 - $26.95 $1.45 Million - $2.18 Million	81,012 New	81,012 $1.55 Million
Q2 2022 Aug 14, 2023	BUY	$16.33 - $22.2 $998,024 - $1.36 Million	61,116 New	61,116 $1.3 Million
Q1 2022 May 12, 2023	SELL	$14.38 - $22.79 $286,104 - $453,429	-19,896 Reduced 24.56%	61,116 $1.18 Million
Q1 2022 May 09, 2022	SELL	$14.38 - $22.79 $3.82 Million - $6.05 Million	-265,393 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$14.98 - $25.5 $3.98 Million - $6.77 Million	265,393 New	265,393 $5.5 Million
Q3 2021 Nov 14, 2022	BUY	$19.28 - $27.1 $1.18 Million - $1.66 Million	61,116 New	61,116 $1.46 Million
Q3 2021 Nov 05, 2021	SELL	$19.28 - $27.1 $1.18 Million - $1.66 Million	-61,116 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$24.42 - $34.75 $1.49 Million - $2.12 Million	61,116 New	61,116 $1.67 Million
Q2 2021 Aug 10, 2021	SELL	$24.42 - $34.75 $1.49 Million - $2.12 Million	-61,116 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$24.47 - $36.98 $1.5 Million - $2.26 Million	61,116 New	61,116 $1.77 Million
Q1 2021 May 07, 2021	SELL	$24.47 - $36.98 $516,708 - $780,869	-21,116 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$17.82 - $31.73 $376,287 - $670,010	21,116 New	21,116 $594,000
Q4 2020 Feb 10, 2021	SELL	$17.82 - $31.73 $376,287 - $670,010	-21,116 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$23.44 - $32.28 $494,959 - $681,624	21,116 New	21,116 $619,000

Others Institutions Holding ARQT

# of Institutions

197

Shares Held

129M

Call Options Held

738K

Put Options Held

82K

Jennison Associates LLC

11.7M
Shares

$108 Million
0.07% of portfolio
Rubric Capital Management LP New York, NY

11M
Shares

$102 Million
2.84% of portfolio
Suvretta Capital Management, LLC New York, NY

10.7M
Shares

$99.3 Million
3.92% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

8.79M
Shares

$81.4 Million
4.4% of portfolio
Black Rock Inc. New York, NY

8.62M
Shares

$79.8 Million
0.0% of portfolio

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $557M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account